1. Home
  2. NHTC vs BOLD Comparison

NHTC vs BOLD Comparison

Compare NHTC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$2.86

Market Cap

37.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.48

Market Cap

36.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHTC
BOLD
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
36.5M
IPO Year
1999
2024

Fundamental Metrics

Financial Performance
Metric
NHTC
BOLD
Price
$2.86
$1.48
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
31.0K
130.8K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
13.51%
N/A
EPS Growth
N/A
32.47
EPS
N/A
N/A
Revenue
$39,776,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.96
52 Week High
$5.10
$1.68

Technical Indicators

Market Signals
Indicator
NHTC
BOLD
Relative Strength Index (RSI) 43.12 48.89
Support Level $2.68 $1.42
Resistance Level $3.32 $1.55
Average True Range (ATR) 0.13 0.09
MACD -0.03 -0.02
Stochastic Oscillator 11.54 20.75

Price Performance

Historical Comparison
NHTC
BOLD

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: